Medical specialists from France tagged as investigators in clinical trials studying Leukemia, Large Granular Lymphocytic

Total 61 results

Adrien TREBOUET, MD
Seen in:
- Lorient, CH de Bretagne Sud
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Alain DELMER, MD
Seen in:
- Reims, Hematology Unit- Hopital Robert Debré
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Alain SAAD, MD
Seen in:
- Beziers, Hematology Service - CH Beziers
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Anne Banos, MD
Seen in:
- Bayonne, CH de la côte Basque
- Bayonne, Centre Hospitalier de la Côte Basque
- Bayonne, Ch La Cote Basque
- Bayonne, Hematology Service - CH de la cote basque
Trials:
- NCT03503409 (Principal Investigator)
- NCT01976182 (Principal Investigator)
- NCT02066454 (Principal Investigator)
- NCT03744390 (Principal Investigator)
- NCT03223961 (Principal Investigator)
Conditions:
Anne Lazareth, MD
Seen in:
- Pierre Benite, Hematology Unit CH LYON SUD
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Anne VEKHOFF, MD
Seen in:
- Paris, Hematology Unit - Hopital Saint Antoine
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Annie BRION, MD
Seen in:
- Besançon, Hematology Service - CH Jean Minjoz
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Arnaud Jaccard, MD
Seen in:
- Limoges, Hematology Unit CHU Dupuytren
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Bernard DRENOU, MD
Seen in:
- Mulhouse, Gh Region Mulhouse Et Sud Alsace
- Mulhouse, Hematology Unit CH E.MULLER
Trials:
- NCT01976182 (Principal Investigator)
- NCT04842877 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia;
- Lymphoma, B-Cell
Bertrand POLLET, MD
Seen in:
- Boulogne sur Mer, Hematology Service - CH Docteur Duchenne
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Caroline DARTIGAS, MD
Seen in:
- Tours, Hematology Unit CHU Bretonneau
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Cécile TOMOWIAC, MD
Seen in:
- Poitiers, Hematology Unit CHU La Miletrie
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Célia SALANOUBAT, MD
Seen in:
- Corbeil Essonnes, Hematology Service CHSF
- Corbeil-Essonnes, CHSF Gilles de Corbeil
Trials:
- NCT01976182 (Principal Investigator)
- NCT03223961 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia;
- Myelodysplastic Syndromes
Charles Bescond, MD
Seen in:
- Cholet, Centre Hospitalier de Cholet
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Daniel ADOUE, PUPH
Seen in:
- Toulouse, Hematology Unit CHU Toulouse
Trials:
- NCT01976182 (Sub-Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Daniel RE, MD
Seen in:
- Antibes, Intern medecine Service - CH Antibes-Juan-les-Pins
- Nice, Oncology Unit CH Antoine Lacassagne
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Eric Jourdan, MD
Seen in:
- Nimes, hematology Unit CHU Caremeau
- Nîmes, CHU DE NIMES _Institut de Cancérologie du Gard
Trials:
- NCT01976182 (Principal Investigator)
- NCT04603495 (Principal Investigator)
Conditions:
Florence Cymbalista, MD
Seen in:
- Bobigny, Hematology Unit - HOpital Avicienne
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
François DREYFUS, MD
Seen in:
- Paris, Hematology Unit - Hopital Hotel Dieu
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Frédérique Orsini-Piocelle, MD
Seen in:
- Pringy, CH Annecy - Hematology Service
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Gaëlle Laboure, MD
Seen in:
- Libourne, CH Robert Boulin
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Guillaume Cartron, MD
Seen in:
- Cedex 05, Montpellier, CHU de Montpellier
- Montpellier, CH Saint-Eloi
- Montpellier, CHU Saint Eloi; Service d'Hématologie Clinique
- Montpellier, Hematogy Unit CHU ST ELOI
- Montpellier, Hopital Saint Eloi
Trials:
- NCT01976182 (Principal Investigator)
- NCT03697512 (Principal Investigator)
- NCT04531046 (Principal Investigator)
- NCT05529524 (Principal Investigator)
- NCT06006117 (Principal Investigator)
Conditions:
Hugo GONZALEZ, MD
Seen in:
- Pontoise, Hematology Unit CH René DUBOS
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
hussam SAAD, MD
Seen in:
- Brest, Hematology Service - CH de Brest
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Jean Michel MICLEA, MD
Seen in:
- Chartres, hematology Service - CH Louis Pasteur
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Jean-François VIALLARD, PUPH
Seen in:
- Pessac, Hematology Service- CH Haut Leveque
Trials:
- NCT01976182 (Sub-Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Jean-Pierre MAROLLEAU, MD
Seen in:
- Amiens, CHU Sud
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Jean-Pierre VILQUE, MD
Seen in:
- Caen, Hematology Service - CH François Baclesse
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia
Jean-Valère MALFUSON, MD
Seen in:
- Clamart, HIA Percy
- Clamart, Hopital Inter-Armées Percy
Trials:
- NCT01976182 (Principal Investigator)
- NCT02473146 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia;
- Acute Myeloid Leukemia
Jehan DUPUIS, MD
Seen in:
- Creteil, CHU Henri Mondor Lymphoid Hemopathy Unit
Trials:
- NCT01976182 (Principal Investigator)
Conditions:
- Large Granular Lymphocytes Leukemia

Clinical Trials on Leukemia, Large Granular Lymphocytic

National Cancer Institute (NCI)

Completed

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

T-Cell Large Granular Lymphocytic Leukemia | Leukemia, T-Cell Large Granular Lymphocytic

United States
Abcuro, Inc.

Recruiting

ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

T-cell Large Granular Lymphocytic Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
EUSA Pharma, Inc.

Recruiting

Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)

Large Granular Lymphocyte Leukemia

United States
John Reneau

Recruiting

Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia

T-Cell Large Granular Lymphocyte Leukemia

United States
John Reneau
Bristol-Myers Squibb

Recruiting

Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia

T-Cell Large Granular Lymphocyte Leukemia

United States
German CLL Study Group

Terminated

Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia

T-Cell Large Granular Lymphocytic Leukemia

Germany
National Cancer Institute (NCI)

Terminated

Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia

T-cell Large Granular Lymphocyte Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage III Small Lymphocytic Lymphoma | Stage IV Small Lymphocytic Lymphoma | T-Cell Large Granular Lymphocyte Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage...

United States, Denmark, Italy
Rennes University Hospital

Active, not recruiting

Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (Methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia (LGL)

Large Granular Lymphocytes Leukemia

France
National Cancer Institute (NCI)

Terminated

Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia

Large Granular Lymphocytic Leukemia | LGL Leukemia

United States

Medical specialists from France tagged as investigators in clinical trials studying Leukemia, Large Granular Lymphocytic

Clinical Trials on Leukemia, Large Granular Lymphocytic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations